S&P 500
Nasdaq
Dow Jones
NVDA
AAPL
TSLA
MSFT
BTC-USD
15-min delayed
Live
Home Market News Price Targets Penny Stocks Crypto Economy Commodities Education
Stocks About Contact

Burning Rock Biotech Limited American Depositary Shares

BNR XNAS
$19.81 +1.24 (+6.68%) ▲ 15-min delayed
Open
$19.00
High
$22.50
Low
$18.50
Volume
34.4K
Market Cap
$199.94M

About Burning Rock Biotech Limited American Depositary Shares

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

Employees: 674 Website →

Earnings & Analyst Ratings

Next Earnings: Thu, Jun 4, 2026
Calendar →

Related Market News

No specific coverage for BNR yet. Check out our latest market news or earnings calendar.

Get BNR Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Burning Rock Biotech Limited American Depositary Shares.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.